Condition: Mesial Temporal Lobe Epilepsy · Sponsor: Neurona Therapeutics
This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with drug-resistant unilateral mesial temporal lobe epilepsy (MTLE), with or without mesial temporal sclerosis (MTS), is safe (frequency of adverse events) and effective (seizure frequency). NRTX-1001 comprises human interneurons that secrete a neurotransmitter, gamma-aminobutyric acid (GABA).
This description comes directly from the study's public registry record.
Neurona MedInfo · 650-580-3825 · neuronamedinfo@neuronatx.com
Eduardo Dunayevich, MD · 650-436-3045 · edunayevich@neuronatx.com
Always discuss trial participation with your own doctor first.
| University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic Arizona Epilepsy Center | Phoenix, Arizona, United States | Recruiting |
| Banner-University of Arizona Medical Center Tucson Comprehensive Epilepsy Program | Tucson, Arizona, United States | Recruiting |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| University of Southern California Keck Hospital | Los Angeles, California, United States | Recruiting |
| University of California Los Angeles | Los Angeles, California, United States | Recruiting |
| UC Irvine Medical Center | Orange, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| University of California Davis | Sacramento, California, United States | Recruiting |
| University of California San Diego | San Diego, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05135091